Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Taback, Bret
Columbia University Medical Center
P2: Incidence of lymph node involvement in clinically node-negative breast cancer patients following neoadjuvant chemotherapy and identification of clinicopathologic features which may lead to omission of sentinel lymph node biopsy
Location:SSO HUB: Breast & Endocrine Zone
Bret Taback
Tabayoyong, William
University of Rochester Medical Center
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
William Tabayoyong
Tadros, Audree
Memorial Sloan Kettering Cancer Center
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Audree Tadros
P11: Satisfaction and well-being after contralateral prophylactic mastectomy among BRCA mutation carriers and non-carriers: a longitudinal analysis of BREAST-Q domains
Location:SSO HUB: Breast & Endocrine Zone
Audree Tadros
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Audree Tadros
Taghian, Alphonse
Massachusetts General Hospital
9: Breast cancer-related lymphedema and its relationship to major landmark trials in surgical oncology and radiation oncology
Location:Veterans Memorial Auditorium
Alphonse Taghian
Takahashi, Hideo
Icahn School of Medicine at Mount Sinai
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Hideo Takahashi
Takeuchi, Masashi
Keio University School of Medicine
GPPO6: The usefulness of presepsin as a diagnostic marker of postoperative infectious complications after esophagectomy
Location:Ballroom C
Masashi Takeuchi
Tamirisa, Nina
MD Anderson Cancer Center
16: Association of Medicaid Expansion with reduction in racial disparities in the timely delivery of up-front surgical care for patients with early stage breast cancer
Location:Veterans Memorial Auditorium
Nina Tamirisa
Perimeter Industry Spotlight Sesson: Managing Margins: Using OCT to Defend Against the Unknown
Location:SSO HUB Theater
Nina Tamirisa
Tan, Antoinette
Levine Cancer Institute, Atrium Health
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Antoinette Tan
Tang, Chih-Min
UC San Diego
76: Single nuclei RNAseq Reveals Dedifferentiation States from Human ICCs to GIST
Location:Ballroom A
Chih-Min Tang
Tang, Laura
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Laura Tang
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Laura Tang
Tan, Marcus
Vanderbilt University Medical Center
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Marcus Tan
Tardy, Katherine
University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Katherine Tardy
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)
Location:Ballroom A
Katherine Tardy
Tausch, Christoph
Breast Center Zurich, Zurich, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Christoph Tausch
Taylor, Bradley
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Bradley Taylor
Tchou, Julia
University of Pennsylvannia
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Julia Tchou
Tee, May
Howard University College of Medicine
Surgical Quality Improvement with Wound Protectors for Whipple Resections and Solumedrol for Major Hepatectomy
Location:SSO HUB: Immuno-Oncology Zone
May Tee
Temple, Larissa
University of Rochester, New York New York
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Larissa Temple
Treatment of Low Anterior Resection Syndrome
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Larissa Temple
Terando, Alicia
Huntington Hospital Cancer Center, an Affiliate of Cedars Sinai Cancer
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Alicia Terando
Melanoma Poster Presentations 2
Location:SSO HUB: Melanoma & Sarcoma Zone
Alicia Terando
Teshome, Mediget
The University of Texas MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Mediget Teshome
Disparities and Quality Improvement and Parallel Session
Location:Ballroom B
Mediget Teshome
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Mediget Teshome
Tevis, Sarah
Department of Surgery, University of Colorado Anschutz Medical Campus
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Sarah Tevis
Thalji, Sam
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Sam Thalji
Thanh Lam, Giang
Breast Center, University Hospital of Geneva, Geneva, Switzerland
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Giang Thanh Lam
Thiagarajan, Ramcharan
LSU HSC New Orleans
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes
Location:Ballroom A
Ramcharan Thiagarajan
Thiels, Cornelius
Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Cornelius Thiels
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Cornelius Thiels
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Cornelius Thiels
P61: Outcomes After Resection of Locally Recurrent Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Cornelius Thiels
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Cornelius Thiels
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Cornelius Thiels
Thomas, Craig
National Center for Advancing Translational Sciences
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Craig Thomas
Thomas, Giju
Vanderbilt University
P21: Utility of near infrared autofluorescence detection of small bowel neuroendocrine tumors to guide extent of resection
Location:SSO HUB: Breast & Endocrine Zone
Giju Thomas
Thomas, Madeline
University of Colorado School of Medicine, Department of Surgery
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Madeline Thomas
Thomas, Rebecca
Nortwell Health
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Rebecca Thomas
Thomas, Samantha
Biostatistics and Bioinformatics, Duke University
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Samantha Thomas
P10: High Risk Screening in Women with BRCA1/2 Mutations Age 70 and Above
Location:SSO HUB: Breast & Endocrine Zone
Samantha Thomas
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Samantha Thomas
Thompson, Alastair
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Alastair Thompson
Thompson, Hannah
Department of Surgery, Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Hannah Thompson
Thompson, John
Melanoma Institute Australia, The University of Sydney
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
John Thompson
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
John Thompson
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
John Thompson
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
John Thompson
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
John Thompson
P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis
Location:SSO HUB: Melanoma & Sarcoma Zone
John Thompson
Thorpe, Steven
University of California, Davis
Case Presentation and Discussion
Location:Ballroom A
Steven Thorpe
Throckmorton, Alyssa
BMG Memphis Breast Care
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Alyssa Throckmorton
Tieniber, Andrew
University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Andrew Tieniber
Ting, David
Massachusetts General Hospital Cancer Center
P15: Relationship of Repeat RNA Expression in Cancer Metastasis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
David Ting
Tirotta, Fabio
University Hospital Birmingham NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Fabio Tirotta
Toesca, Antonio
Candiolo Cancer Institute, FPO - IRCCS, Italy
"How I Do It” – International Perspectives on Robotic NSM
Location:SSO HUB: Breast & Endocrine Zone
Antonio Toesca
Tolaney, Sara
Dana-Farber Cancer Institute
PeerView Independent Satellite Symposium: Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
Location:Room 304
Sara Tolaney
Tomassini, Lorenzo
Colombia
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
Lorenzo Tomassini
Tong, Barry
University of California, San Francisco
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Barry Tong
Toprani, Rajendra
HCG Cancer Center, Ahmedabad, India
Between Patient and Policy Maker - What We Can do to Build Global Capacity for Cancer Surgery
Location:Ballroom A
Rajendra Toprani
Torphy, Robert
University of Colorado
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Robert Torphy
Torres-Ayuso, Pedro
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Pedro Torres-Ayuso
Tran Cao, Hop
The University of Texas MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Hop Tran Cao
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Hop Tran Cao
PRO: Neoadjuvant Therapy Should be Routinely Given for High-risk Intrahepatic Cholangiocarcinoma
Location:Ballroom A
Hop Tran Cao
Rebuttal and Discussion
Location:Ballroom A
Hop Tran Cao
Tran, Thuy
University of California, Irvine
P65: A National Assessment of Differences in Gastric Cancer Outcomes Among Asian Ethnic Subgroups
Location:SSO HUB: Rare/Metastatic Cancers Zone
Thuy Tran
Truty, Mark
Mayo Clinic Rochester
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Mark Truty
70: Oncologic outcomes of cytoreductive surgery and HIPEC for highly selected patients with pancreatic ductal adenocarcinoma
Location:Ballroom B
Mark Truty
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mark Truty
P61: Outcomes After Resection of Locally Recurrent Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Mark Truty
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Mark Truty
Tsai, Katy
Helen Diller Family Comprehensive Cancer Center Cutaneous Oncology
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Katy Tsai
Tsai, Susan
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Susan Tsai
Tseng, Jennifer
Job Negotiation: The Chair Perspective
Location:Room 302
Jennifer Tseng
Tseng, Joshua
Cedars-Sinai Medical Center - Los Angeles, CA
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Joshua Tseng
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Joshua Tseng
Tsilimigras, Diamantis
The Ohio State Wexner Medical Center
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Diamantis Tsilimigras
Tsung, Allan
University of Virginia
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Allan Tsung
Prehabilitation: Basic Scientific and Translational Aspects
Location:SSO HUB: Rare/Metastatic Cancers Zone
Allan Tsung
Tung, Shawndeep
MemorialCare Cancer Institute
Perimeter Industry Spotlight Sesson: Managing Margins: Using OCT to Defend Against the Unknown
Location:SSO HUB Theater
Shawndeep Tung
Tunsiricharoengul, Sasha
Harvard University
P48: Increased Frequency of Gene Mutations Significantly Decreases Recurrence Risk In High-Risk Stage II Melanoma Patients.
Location:SSO HUB: Melanoma & Sarcoma Zone
Sasha Tunsiricharoengul
Turaga, Kiran
Yale University
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Kiran Turaga
Understanding RVUs, Billing & Coding
Location:Room 302
Kiran Turaga
Turgeon, Alexis
CHU de québec
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Alexis Turgeon
Turner, Michael
University of California, San Diego
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Michael Turner
Tyler, Doug
University of Texas Medical Branch
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Doug Tyler
Thing of the Past
Location:Ballroom C
Doug Tyler
Rebuttal and Q&A
Location:Ballroom C
Doug Tyler
Tzeng, Ching-Wei
The University of Texas MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Ching-Wei Tzeng
Disparities and Quality Improvement and Parallel Session
Location:Ballroom B
Ching-Wei Tzeng
P39: Effect of Surgical Approach on Early Return to Intended Oncologic Therapy After Resection for Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Ching-Wei Tzeng
Practical and Pragmatic Prehab
Location:SSO HUB: Rare/Metastatic Cancers Zone
Ching-Wei Tzeng
Back to Top
